Enzolytics Inc

Enzolytics Inc. is a biotechnology company based in Texas that specializes in the development and commercialization of proprietary proteins and monoclonal antibodies aimed at treating debilitating infectious diseases, including HIV, Hepatitis A and B, rabies, and COVID-19. With over 40 years of excellence in drug development, the company is committed to creating effective and affordable therapeutics to improve global health.

The company employs innovative technologies to produce fully human monoclonal antibodies through a proprietary methodology, enabling the development of therapeutics that target various infectious diseases. Enzolytics also collaborates with multiple partners and research institutions to advance its drug development initiatives and clinical testing efforts.

Generated from the website